TITRATION OF HUMAN-BOVINE ROTAVIRUS REASSORTANTS USING A TETRAZOLIUM-BASED COLORIMETRIC END-POINT DILUTION ASSAY

被引:14
作者
DISTEFANO, DJ
GOULD, SL
MUNSHI, S
ROBINSON, DK
机构
[1] Department of Cellular and Molecular Biology, Merck Research Laboratories, Rahway
关键词
ROTAVIRUS; END-POINT DILUTION; TETRAZOLIUM; COLORIMETRIC ASSAY;
D O I
10.1016/0166-0934(95)00057-2
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A colorimetric end-point dilution assay was developed for the titration of rotavirus-containing samples that uses commercially available tetrazolium dyes as an indicator of virus infection. This assay offers several advantages over both plaque assays and traditional end-point dilution methods. The latter assays require manual counting of plaques or the scoring of wells for the presence of virus based on observed cytopathic effects. The colorimetric end-point dilution assay enables the scoring of wells based upon absorbance readings alone, thereby eliminating time-consuming and subjective manual screenings. This method also has the potential for automating the analysis of large numbers of samples. Virus titers of human-bovine rotavirus reassortants obtained using this method are comparable to those determined by plaque assay. The scoring of wells based on absorbance readings was also found to agree with manual scoring of cytopathic effects and with the production of viral antigen.
引用
收藏
页码:199 / 208
页数:10
相关论文
共 17 条
[1]   DEVELOPMENT OF A ROTAVIRUS PLAQUE-ASSAY USING SEPHADEX G-75 [J].
AHA, PM ;
SABARA, MI .
JOURNAL OF VIROLOGICAL METHODS, 1990, 28 (01) :25-32
[2]  
ALLEY MC, 1988, CANCER RES, V48, P589
[3]   DEVELOPMENT OF CANDIDATE ROTAVIRUS VACCINES [J].
BISHOP, RF .
VACCINE, 1993, 11 (02) :247-254
[4]  
BUTCHAIAH G, 1988, ACTA VIROL, V32, P60
[5]   SEROTYPE-1 REASSORTANT OF BOVINE ROTAVIRUS WC3, STRAIN WI79-9, INDUCES A POLYTYPIC ANTIBODY-RESPONSE IN INFANTS [J].
CLARK, HF ;
BORIAN, FE ;
MODESTO, K ;
PLOTKIN, SA .
VACCINE, 1990, 8 (04) :327-332
[6]  
Eisen HN., 1972, MICROBIOLOGY, P1044, DOI DOI 10.1371/journal.pone.0141383
[7]   PROTEOLYTIC ENHANCEMENT OF ROTAVIRUS INFECTIVITY - MOLECULAR MECHANISMS [J].
ESTES, MK ;
GRAHAM, DY ;
MASON, BB .
JOURNAL OF VIROLOGY, 1981, 39 (03) :879-888
[8]   ROTAVIRUS VACCINATION - CURRENT STATUS - A BRIEF SUMMARY [J].
GREENBERG, HB .
BIOTECHNOLOGY R&D TRENDS: SCIENCE POLICY FOR DEVELOPMENT, 1993, 700 :32-35
[9]   A SENSITIVE PLAQUE-ASSAY FOR BOVINE ROTAVIRUS IN CULTURES OF THE BOVINE CELL-LINE GBK [J].
HIRANO, N ;
SATO, F ;
ONO, K ;
MURAKAMI, T ;
MATUMOTO, M .
VETERINARY MICROBIOLOGY, 1987, 13 (04) :383-387
[10]   PROTEOLYTIC ENHANCEMENT OF HUMAN ROTAVIRUS INFECTIVITY [J].
KONNO, T ;
SUZUKI, H ;
KITAOKA, S ;
SATO, T ;
FUKUHARA, N ;
YOSHIE, O ;
FUKUDOME, K ;
NUMAZAKI, Y .
CLINICAL INFECTIOUS DISEASES, 1993, 16 :S92-S97